The Journal of Allergy and Clinical Immunology 2003: Vol 111 Index

53 Pages·2003·13.8 MB·English

index to volume 111
Author index*
A HI. Modifiable barriers to adherence to inhaled steroids
Aaby P (see Bager et al). 2003;111:1227-31 among adults with asthma: It’s not just black and white
Aarab M (see Verster et al). 2003:111:623-7 2003;111:1219-26
Abe S (see Wen et al). 2003;111:1307-18 Apter AJ. Clinical advances in adult asthma.
Accordini S (see Verlato et al). 2003;111:1232-8 2003;111:S780-S784
Acero-Sainz S (see Tabar-Purroy et al). 2003;111:415-9 Apter AJ. Early exposure to allergen: Is this the cat’s
Adachi M (see Matsukura et al). 2003;111:1337-44 meow, or are we barking up the wrong tree?
Adachi M (see Sano et al). 2003;111:958-66 2003; 111:938-46
Adachi T, Stafford S, Kayaba H, Chihara J, Alam R Apter AJ (see George et al). 2003;111:967-73
Myosin light chain kinase mediates eosinophil chemo Arango P (see Steinke et al). 2003;111:342-9
taxis In a mitogen-activated protein kinase—dependent Arase S (see Watanabe et al). 2003;111:587-91
manner. 2003;111:113-6 Araujo MI (see Medeiros et al). 2003;111:947-51
Addis A (see Moretti et al). 2003;111:479-83 Arbes SJ Jr, Cohn RD, Yin M, Muilenberg ML, Burge HA,
Adkinson NF Jr (see Hamilton and Adkinson) Friedman W, Zeldin DC. House dust mite allergen in
2003:111:S687-S701 US beds: results from the first national survey of lead
Aharonovich A (see Diav-Citrin et al). 2003;111:1239-43 and allergens in housing. 2003;111:408-14
Alam R, Gorska M. Lymphocytes. 2003;111:S476-S485 Arbes SJ Jr (see Chulada et al). 2003;111:328-36
Alam R (see Adachi et al). 2003:111:113-6 Arduino JM (see Meyer et al). 2003;111:757-62
Alenius H (see Palosuo et al). 2003;111:1386-92 Arif SAM (see Bernstein et al). 2003;111:610-6
Alford BA (see Samee et al). 2003;111:1205-11 Arlian LG, Vyszenski-Moher DL, Morgan MS. Mite and
(Rapid publications) mite allergen removal during machine washing of laun
Allison AB (see Platts-Millse t al). 2003:111:123-30 dry. 2003:111:1269-73
Almeida MC (see Medeiros et al). 2003;111:947-51 Arnon J (see Diav-Citrin et al). 2003;111:1239-43
Almqvist C, Egmar A-C, van Hage-Hamsten M, Berglind Artwohl J (see Konduri et al). 2003;111:321-7
N, Pershagen G, Nordvall SL, Svartengren M, Hedlin Asahina A (see Kakinuma et al). 2003;111:592-7
G, Wickman M. Heredity, pet ownership, and con Asano N (see Kakinuma et al). 2003;111:592-7
founding control in a population-based birth cohort Asero R. Fixed drug eruptions caused by tonic water
2003:111:800-6 2003;111:198-9 (Letters to the editor)
Altes T (see Samee et al). 2003;111:1205-11 Asero R. Intolerance to nonsteroidal anti-inflammatory
(Rapid publications) drugs might precede by years the onset of chronic
Altmann F (see Foetisch et al). 2003:111:889-96 urticaria. 2003;111:1095-8
Alvarez-Puebla MJ (see Tabar-Purrovy et al). 2003:111:415-9 Asero R, Lorini M, Tedeschi A. Association of chronic
Anand MK, Nelson HS, Dreskin SC. A possible role for urticaria with thyroid autoimmunity and Raynaud phe
cyclooxygenase 2 inhibitors in the treatment of chronic nomenon with anticentromere antibodies
urticaria. 2003;111:1133-6 (Letters to the editor) 2003;111:1129-30 (Letters to the editor)
Andersen LP (see Linneberg et al). 2003;111:847-53 Asero R. Sex differences in the pathogenesis of chronic
Anderson-Cohen M (see Jirapongsananuruk et al) urticaria. 2003;111:425-6 (Letters to the editor)
2003:111:374-9 Ashby M (see Corren et al). 2003;111:87-90
Anderson SD, Fitch K, Perry CP, Sue-Chu M, Crapo R (Brief communication)
McKenzie D, Magnussen H. Responses to bronchial Atkinson JP (see Brasington et al). 2003;111:S593-S601
challenge submitted for approval to use inhaled B2-ago Atta AM (see Medeiros et al). 2003:111:947-51
nists before an event at the 2002 Winter Olympics Azuma T (see Sato et al). 2003;111:143-8
2003:111:45-50
Annunziato F (see Brugnolo et al). 2003;111:380-8 B
Aoshiba K (see Tamaoki et al). 2003;111:197-8 Bachert C, Gevaert P, Howarth P, Holtappels G, van
(Letters to the editor) Cauwenberge P, Johansson SGO. IgE to Staphylococcus
Apter AJ, Boston RC, George M, Norfleet AL, Tenhave T, aureus enterotoxins in serum 1s related to severity ot
Coyne JC, Birck K, Reisine ST, Cucchiara AJ, Feldman asthma. 2003;111:1131-2 (Letters to the editor)
Bachert C (see Wahn et al). 2003;111:763-9
Baena-Cagnani C (see Wahn et al). 2003-;111:763-9
Bager P, Melbye M, Rostgaard K, Benn CS, Westergaard
lr’. Mode of delivery and risk of allergic rhinitis and
asthma. 2003;111:51-6
index to volume 111
Author index*
A HI. Modifiable barriers to adherence to inhaled steroids
Aaby P (see Bager et al). 2003;111:1227-31 among adults with asthma: It’s not just black and white
Aarab M (see Verster et al). 2003:111:623-7 2003;111:1219-26
Abe S (see Wen et al). 2003;111:1307-18 Apter AJ. Clinical advances in adult asthma.
Accordini S (see Verlato et al). 2003;111:1232-8 2003;111:S780-S784
Acero-Sainz S (see Tabar-Purroy et al). 2003;111:415-9 Apter AJ. Early exposure to allergen: Is this the cat’s
Adachi M (see Matsukura et al). 2003;111:1337-44 meow, or are we barking up the wrong tree?
Adachi M (see Sano et al). 2003;111:958-66 2003; 111:938-46
Adachi T, Stafford S, Kayaba H, Chihara J, Alam R Apter AJ (see George et al). 2003;111:967-73
Myosin light chain kinase mediates eosinophil chemo Arango P (see Steinke et al). 2003;111:342-9
taxis In a mitogen-activated protein kinase—dependent Arase S (see Watanabe et al). 2003;111:587-91
manner. 2003;111:113-6 Araujo MI (see Medeiros et al). 2003;111:947-51
Addis A (see Moretti et al). 2003;111:479-83 Arbes SJ Jr, Cohn RD, Yin M, Muilenberg ML, Burge HA,
Adkinson NF Jr (see Hamilton and Adkinson) Friedman W, Zeldin DC. House dust mite allergen in
2003:111:S687-S701 US beds: results from the first national survey of lead
Aharonovich A (see Diav-Citrin et al). 2003;111:1239-43 and allergens in housing. 2003;111:408-14
Alam R, Gorska M. Lymphocytes. 2003;111:S476-S485 Arbes SJ Jr (see Chulada et al). 2003;111:328-36
Alam R (see Adachi et al). 2003:111:113-6 Arduino JM (see Meyer et al). 2003;111:757-62
Alenius H (see Palosuo et al). 2003;111:1386-92 Arif SAM (see Bernstein et al). 2003;111:610-6
Alford BA (see Samee et al). 2003;111:1205-11 Arlian LG, Vyszenski-Moher DL, Morgan MS. Mite and
(Rapid publications) mite allergen removal during machine washing of laun
Allison AB (see Platts-Millse t al). 2003:111:123-30 dry. 2003:111:1269-73
Almeida MC (see Medeiros et al). 2003;111:947-51 Arnon J (see Diav-Citrin et al). 2003;111:1239-43
Almqvist C, Egmar A-C, van Hage-Hamsten M, Berglind Artwohl J (see Konduri et al). 2003;111:321-7
N, Pershagen G, Nordvall SL, Svartengren M, Hedlin Asahina A (see Kakinuma et al). 2003;111:592-7
G, Wickman M. Heredity, pet ownership, and con Asano N (see Kakinuma et al). 2003;111:592-7
founding control in a population-based birth cohort Asero R. Fixed drug eruptions caused by tonic water
2003:111:800-6 2003;111:198-9 (Letters to the editor)
Altes T (see Samee et al). 2003;111:1205-11 Asero R. Intolerance to nonsteroidal anti-inflammatory
(Rapid publications) drugs might precede by years the onset of chronic
Altmann F (see Foetisch et al). 2003:111:889-96 urticaria. 2003;111:1095-8
Alvarez-Puebla MJ (see Tabar-Purrovy et al). 2003:111:415-9 Asero R, Lorini M, Tedeschi A. Association of chronic
Anand MK, Nelson HS, Dreskin SC. A possible role for urticaria with thyroid autoimmunity and Raynaud phe
cyclooxygenase 2 inhibitors in the treatment of chronic nomenon with anticentromere antibodies
urticaria. 2003;111:1133-6 (Letters to the editor) 2003;111:1129-30 (Letters to the editor)
Andersen LP (see Linneberg et al). 2003;111:847-53 Asero R. Sex differences in the pathogenesis of chronic
Anderson-Cohen M (see Jirapongsananuruk et al) urticaria. 2003;111:425-6 (Letters to the editor)
2003:111:374-9 Ashby M (see Corren et al). 2003;111:87-90
Anderson SD, Fitch K, Perry CP, Sue-Chu M, Crapo R (Brief communication)
McKenzie D, Magnussen H. Responses to bronchial Atkinson JP (see Brasington et al). 2003;111:S593-S601
challenge submitted for approval to use inhaled B2-ago Atta AM (see Medeiros et al). 2003:111:947-51
nists before an event at the 2002 Winter Olympics Azuma T (see Sato et al). 2003;111:143-8
2003:111:45-50
Annunziato F (see Brugnolo et al). 2003;111:380-8 B
Aoshiba K (see Tamaoki et al). 2003;111:197-8 Bachert C, Gevaert P, Howarth P, Holtappels G, van
(Letters to the editor) Cauwenberge P, Johansson SGO. IgE to Staphylococcus
Apter AJ, Boston RC, George M, Norfleet AL, Tenhave T, aureus enterotoxins in serum 1s related to severity ot
Coyne JC, Birck K, Reisine ST, Cucchiara AJ, Feldman asthma. 2003;111:1131-2 (Letters to the editor)
Bachert C (see Wahn et al). 2003;111:763-9
Baena-Cagnani C (see Wahn et al). 2003-;111:763-9
Bager P, Melbye M, Rostgaard K, Benn CS, Westergaard
lr’. Mode of delivery and risk of allergic rhinitis and
asthma. 2003;111:51-6
J ALLERGY CLIN IMMUNOL Author index 1427
VOLUME 111, NUMBER 6
Bager P, Westergaard T, Rostgaard K, Nielsen NM, Melbye treatment with aspirin desensitization in asthmatic
M, Aaby P. Smallpox vaccination and risk of allergy patients with aspirin-exacerbated respiratory disease.
and asthma. 2003;111:1227-31 2003;111:180-6
Baldo BA (see Brown et al). 2003:111:187-92 Bergiind N (see Almqvist et al). 2003;111:800-6
Ballmer-Weber B-K (see Hoff et al). 2003:111:1106-10 Berkovitch M (see Moretti et al). 2003;111:479-83
Ballow M (see Nelson and Ballow). 2003;111:S720-S732 Bernardini R, Novembre E, Lombardi E, Pucci N, Monaco
Balzar S (see Wenzel et al). 2003;111:1345-52 MG, Vierucci A, Marcucci F. Risk factor for latex aller-
Bannon GA (see Pomeés et al). 2003;111:640-5 gy in 54 children with atopy and latex sensitization.
Bar-Oz B (see Moretti et al). 2003;111:479-83 2003;111:199-200 (Letters to the editor)
Barber D (see Diaz-Perales wt al). 2003:111:628-33 Bernardini R (see Novembre et al). 2003;111:1405-6
Barber D (see Sastre et al). 2003;111:985-94 (Letters to the editor)
Bardana, EJ Jr. Occupational asthma and allergies Berning S (see Bender et al). 2003;111:770-6
2003:111:S530-S539 Bernstein C (see Bernstein et al). 2003;111:610-6
Barderas R, Villaba M, Batanero E, Pascual CY, Rodriguez Bernstein DI, Biagini RE, Karnani R, Hamilton R, Murphy
R. Role of profilin and polcalcin in chenopod pollen K, Bernstein C, Arif SAM, Berendts B, Yeang HY. In
allergy. 2003;111:1132-3 (Letters to the editor) Vivo sensitization to purified Hevea brasiliensis proteins
Bardina L (see Kelso et al). 2003;111:901 in health care workers sensitized to natural rubber latex.
(Letters to the editor) 2003;111:610-6
Barnes J (see Hallsworth et al). 203;111:251-5 (Rostrum) Bernstein JA. Genetic association studies: what are they
Barr M (see Platts-Mills et al). 2003:111:123-30 teaching clinicians? 2003;111:465-6 (Editorial)
Bartz H (see Feuchtinger et al). 2003;111:428-30 Beyer K (see Kelso et al). 2003;111:901
(Letters to the editor) (Letters to the editor)
Batanero E (see Barderas et al). 2003:111:1132-3 Biagini RE (see Bernstein et al). 2003;111:610-6
(Letters to the editor) Bieber T (see Novak et al). 2003;111:38-44 (Rostrum)
Bates CA, Silkoff PE. Exhaled nitric oxide in asthma: from Bijtjes SIR (see Verster et al). 2003;111:623-7
bench to bedside. 2003:111:256-62 (Rostrum) Binstadt BA, Geha RS, Bonilla FA. IgG Fe receptor poly-
Bates CE (see Lee et al). 2003;111:337-41 morphisms in human disease: implications for intra-
BauerC (see Sengler et al). 2003;111:515-9 venous immunoglobulin therapy. 2003;111:697-703
Bauer CP (see von Berg et al). 2003;111:533-40 (Rostrum)
Baur X. Cotton fluffs as latex allergen carriers in a glove Birck K (see Apter et al). 2003;111:1219-26
factory. 2003:111:177-9 Bischoff SC (see Lorentz et al). 2003;111:1062-8
Baur X. Epidemiology of latex sensitization. 2003;111:652 Bisgaard H (see Meyer et al). 2003;111:757-62
(Correspondence) Bisgaard H (see Sampson et al). 2003;111:S49-S6]
Beaty TH (see Colilla et al). 2003:111:840-6 Bishop S (see Gore et al). 2003;111:784-7
Beaucher W (see Melamed and Beaucher). 2003;111:648- Blaiss MS (see Casale et al). 2003;111:S835-S842
50 (Letters to the editor) Blanc PD (see Cisternas et al). 2003;111:1212-8
Beck L (see Eichenfield and Beck). 2003;111:1153-68 Blaser K (see Schmid-Grendelmeier et al). 2003;111:1328-36
(New products) Blauvelt A, Hwang ST, Udey MC. Allergic and immuno-
Bellinghausen I, Klostermann B, Knop J, Saloga J. Human logic diseases of the skin. 2003;111:S560-S570
CD4*CD25* T cells derived from the majority of atopic Bleecker ER (see Colil'a et al). 2003;111:840-6
donors are able to suppress T,,1 and T,,2 cytokine pro- Bloom JW (see Leung and Bloom). 2003;111:3-22
duction. 2003:111:862-8 Blumenthal K (see Platts-Mills et al). 2003;111:123-30
BelousovaEG (see Marks et al). 2003:111:541-9 Blumenthal MN (see Colilla et al). 2003;111:840-6
Bender BG, Berning S, Dudden R, Milgrom H, Tran ZV Bochenek G, Nagraba K, Nizankowska E, Szczeklik A. A
Sedation and performance impairment of diphenhy- controlled study of 9a,11B-PGF, (a prostaglandin D,
dramine and second-generation antihistamines: a meta- metabolite) in plasma and urine of patients with
analysis. 2003;111:770-6 bronchial asthma and healthy controls after aspirin
Bender BG. In the eye of the patient. 2003;111:936-7 (Edi- challenge. 2003;111:743-9
torial) Bochenek G (see Gyllfors et al). 2003;111:1116-21
Bender BG, Leung SB, Leung DYM. Actigraphy assess- Bochner BS, Hamid Q. Advances in mechanisms of aller-
ment of sleep disturbance in patients with atopic der- gy. 2003;111:S819-S823
matitis: an objective life quality measure. Bodtger U, Poulsen LK, Malling H-J. Asymptomatic skin
2003;111:598-602 sensitization to birch predicts later development of
Bender BG (see Ho et al). 2003:111:498-502 birch pollen allergy in adults: a 3-year follow-up study.
Benfeldt E (see Rosenfeldt et al). 2003;111:389-95 2003; 111:149-54
Benn CS (see Bager et al). 2003;111:51-6 Boguniewicz M (see Leung and Boguniewicz).
Berdel D (see von Berg et al). 2003;111:533-40 2003;111:S805-S812
Berendts B (see Bernstein et al). 2003;111:610-6 Boguniewicz M (see Toda et al). 2003;111:875-81
Berges-Gimeno MP, Simon RA, Stevenson DD. Long-term Bohle B (see Himly et al). 2003;111:882-8
1428 Author index J ALLERGY CLIN IMMUNOL
JUNE 2003
Bonilla FA, Geha RS. Primary immunodeficiency diseases Busse W, Koenig SM, Oppenheimer J, Sahn SA, Yancey
2003;111:S571-S581 SW, Reilly D, Edwards LD, Dorinsky PM. Steroid-
onilla FA (see Binstadt et al). 2003:111:697-703 sparing effects of fluticasone propionate 100 ug and sal-
(Rostrum) meterol 50 ug administered twice daily in a single prod
wish L (see Steinke et al). 2003;111:342-9 uct in patients previously controlled with fluticasone
wish LC, Steinke JW. Cytokines and chemokines propionate 250 ug administered twice daily
2003;111:S460-5475 2003;111:57-65
Borish LC (see Steinke et al). 2003;111:S495-S501 Busse WW, Rosenwasser LJ. Mechanisms of asthma.
Bossé ¥ ee Espinosa et al). 2003;111:1032-40 2003:111:8799-S804
Boston RC (see Apter et al). 2003;111:1219-26 Busse WW (see Kelly et al). 2003;111:79-86
ttomly K (see Herrick et al). 2003;111: 1087-94 Busse WW (see Kessel JM et al). 2003:111:1024-31
uulet L-P (see Chakir et al). 2003:111:1293-8 Busse WW (see Lemanske and Busse). 2003:1 11:S502-S519
uuiygue GR (see Fiocchi et al). 2003;111:193-5 Busse WW (see Leung et al). 2003;111:659-60, 91 1-2,
Letters to the editor) 1169-70
soyvano Martinez MT (see Garcia-Ara et al) Busse WW (see Liu L-Y et <
2003;111:647-8 (Letters to the editor) Bussel JB (see Triveedd i anc u 1) i) $669-S6/6
yyce JA. Mast cells: beyondIg E. 2003:111:24
le MJ (see Wark et al). 2003:111:952-7
idley D (see Steinke et al). 2003;111 , ‘alamari AM (see Pastorello et al). 2003;111:350-9
asington RD Jr, Kahl LE, Ranganathan P, Latinis KM, ‘ampbell H (see Eum et al). 2003;111:1049-61
Velazquez C, Atkinson JP. Immunologic rheumatic dis ampbell J (see Custovic et al). 2003;111:402-7
orders. 2003:111:8593-S60] ampi P (see Brugnolo et al). 2003;111:380-8
auburger J (see Feuchtinger et al). 2003:111:428-30 ‘anonica GW, Passalacqua G. Noninjection routes for
Letters to the editor) immunotherapy. 2003;111:437-48
sraun A (see Erpenbeck et al). 2003;111:1319-27 anonica WG (see Liccardi et al). 2003:111:1410-2
enna O (see Pastorello et al). 2003:111:350-9 (Letters to the editor)
idts C (see Ebo et al). 2003;111:1414 (Correspondence) ‘apasso M (see del Giudice et al). 2003;111:193
itton WJ (see Marks et al). 2003:111:541-9 (Letters to the editor)
ittonWJ (see Mihrshahi et al). 2003:111:162-8 aplan EL, Ford JL, Young PF, Ownby DR. Fire ants rep
ock TP, Williams DM. Community pharmacists as med resent an important risk for anaphylaxis among resi
ication educators. 2003;111:201 (Correspondence) dents of an endemic region. 2003-1 11:1274-7
Ocker EB (see Hahn et al). 2003;111:1361-9 ‘apra L (see Novembre et al). 2003:111:1405-6
srookeman JR (see Samee et al). 2003:111:1205-11 (Letters to the editor)
(Rapid publications) aprara D (see Moretti et al). 2003;111:479-83
vn MR (see Jirapongsananuruk et al). 2003;111:374-9 apristo AF (see del Giudice et al). 2003:111:193
wn SGA, Franks RW, Baldo BA, Heddle RJ. Preva Letters to the editor)
lence erity, and natural history of jack jumper ant apristo C (see del Giudice et al). 2003:111:193
enom allergy in Tasmania. 2003:111:187-92 (Letters to the editor)
srugnolo F, Sampognaro S, Liotta F, Cosmi L, Annunziato I aramori G (see Roche et al). 2003:111:367-73
Manuelli C, Campi P, Maggi E, Romagnani S, Parronchi arballido JM (see Zemann et al). 2003;111: 1069-75
P. The novel synthetic immune response modifier R-848 arolei A (see Verlato et al). 2003:111:1232-8
(Resiquimod) shifts human allergen-specific CD4* T,,2 arper HT (see Zambranoe t al). 2003:111:1008-16
lymphocyte s into IFN-y—-producing cells. 2003;111:380-8 ‘arr D (see Kabesch et al). 2003:111:813
Br 7« Koomen CAFM (see Oostientg al ) arvalho EM (see Medeiros et al). 2003:111:947-5
2003;111:203-4 (Letter reply) asale T (see Corren et al). 2003;111:87-90
Brunese FP (see de! Giudice et al). 2003:111:193 (Brief communication
Letters to the editor asale TB, Blaiss MS, Gelfand E, Gilmore T, Harvey PD,
Buckley RH. Transplantation immunology: organ and bone Hindmarch I, Simons FER, Spangler DL, Szefler SJ,
marrow. 2003;111:8733-S744 Terndrup TE, Waldman SA, Weiler J, Wong DF. First
Bugiani M (see Verlato et al). 2003-111 do no harm: managing antihistamine impairment in
Bunte R (Seé¢ Konduri el al 2003 1] | oi patients with allergic rhinitis. 2003;111:S835-S842
Burchette RJ (see Macy et al). 2003:111 ‘ates EC, Gajewska BU, Goncharova S, Fattouh R, Coyle
Burge H (see Platts-Mills et al). 2003:111 AJ, Gutierrez-Ramos J-C, Jordana M. Effect of GM
Burge HA (see Arbese t al). 2003:111:408-14 CSF on immune, inflammatory, and clinical responses
Burks AW (see Pomése t al). 2003:111:640-5 to ragweed in a novel mouse model of mucosal sensiti
Burks W (see Kelsoe t al). 2003:111:650-1 zation. 2003:111: 1076-86
(Letters to the editor) ‘atuogno J (see Simons et al). 2003;111:1244-8
Burman J (see Menzies-Gow et al). 2003:111:714-9 ‘erveri I (see Verlatoe t al). 2003:111:1232-8
(Rapid publications) ‘hadwick DW (see Naisbitt et al). 2003:111:1393-) 403
J ALLERGY CLIN IMMUNOL Author index 1429
VOLUME 111, NUMBER 6
Chakir J, Shannon J, Molet S, Fukakusa M, Elias J, Lavio- Beaty TH, Bleecker ER, Lange EM, Rich SS, Meyers
lette M, Boulet L-P, Hamid Q. Airway remodeling—asso- DA, Ober C, Cox NJ. Evidence for gene-environment
ciated mediators in moderate to severe asthma: effect of interactions in a linkage study of asthma and smoking
steroids on TGF-, IL-11, IL-17, and type I and type II exposure. 2003:111:840-6
collagen expression. 2003; 11 1:1293-8 Colombo P (see Stumvoll et al). 2003;111:974-9
‘haplin DD. Overview of the immune response. Conforti A (see Dorscheid et al). 2003;111:360-6
2003;111:S442-S459 Connaughton C (see Kelso et al). 2003;111:650-1
‘hapman D (see Simons et al). 2003;111:1244-8 (Letters to the editor)
‘hapman KR (see Sandrini et al). 2003;111:313-20 Conti A (see Pastorello et al). 2003;111:350-9
hapman MD (see Pomés et al). 2003;111:640-5 Cook EF (see Schatz et al). 2003:111:503-8
‘harpin D (see Maccario J et al). 2003;111:750-6 Cooper FJ, Chico ME, Rodrigues LC, Ordonez M, Strachan
‘hen L-C (see Yao et al). 2003;111:1285-92 D, Griffin GE, Nutman TB. Reduced risk of atopy among
‘hen Q (see Zheng et al). 2003;111:720-8 school-age children infected with geohelminth parasites
(Rapid publications) in a rural area of the tropics. 2003;111:995-1000
‘heong N (see Kuo et al). 2003;111:603-9 Corradin G (see Fellrath et al). 2003;111:854-61
‘hhabra SK (see Nadeem et al). 2003;111:72-8 Corren J, Casale T, Deniz Y, Ashby M. Omalizumab, a
‘hiba T (see Watanabe et al). 2003;111:1375-85 recombinant humanized anti-IgE antibody, reduces
hichester K (see Matsui et al). 2003;111:396-401 asthma-related emergency room visits and hospitaliza-
‘hico ME (see Cooper et al). 2003-1 11:995-1000 tions in patients with allergic asthma. 2003;111:87-90
‘hihara J (see Adachi et al). 2003;111:113-6 (Brief communication)
‘hinen J, Rosenblatt HM, Smith EO, Shearer WT, Noroski Corry DB (see Prince et al). 2003-;111:S613-S623
LM. Long-term assessment of T-cell populations in Corsico A (see Verlato et al). 2003;111:1232-8
DiGeorge syndrome. 2003;111:573-9 Cosmi L (see Brugnolo et al). 2003;111:380-8
‘hinen J, Shearer WT. Basic and clinical immunology. ‘outinho CJ (see Moretti et al). 2003;111:479-83
2003:111:S813-S818 ‘ox NJ (see Colilla et al). 2003;111:840-6
‘hinen J (see Moylett et al). 2003;111:1370-4 ‘oyle AJ (see Cates et al). 2003;111:1076-86
‘hitnis T, Khoury SJ. Immunologic neuromuscular disor- ‘oyne JC (see Apter et al). 2003;111:1219-26
ders. 2003:111:S659-S668 ‘rameri R (see Schmid-Grendelmeier et al)
‘hristiansen SC (see Eddleston et al). 2003;111: 106-12 2003;111:1328-36
‘hristodoulopoulos P (see Fiset et al). 2003;111:580-6 ‘rapo R (see Anderson et al). 2003;111:45-50
‘hristodoulopoulos P (see Toda et al). 2003;111:875-81 ‘respo JF (see Rodriguez-Perez et al). 2003;111:634-9
‘hu HW (see Wenzel et al). 2003;111:1345-52 ‘rimi N, Pagano C, Palermo F, Mastruzzo C, Prosperini G,
‘hua KY (see Kuo et al). 2003:111:603-9 Pistorio MP, Vancheri C. Inhibitory effect of a
‘hulada PC, Arbes SJ Jr, Dunson D, Zeldin DC. Breast- leukotriene receptor antagonist (montelukast) on neu-
feeding and the prevalence of asthma and wheeze in rokinin A—induced bronchoconstriction. 2003; 111:833-9
children: analyses from the third national health and ‘rouse CD (see Steinke et al). 2003:111:342-9
nutrition examination survey, !988-1994. ‘ruz AA (see Medeiros et al). 2003;111:947-51
2003:111:328-36 ‘ucchiara AJ (see Apter et al). 2003;111:1219-26
‘hung KF (see Roche et al). 2003;111:367-73 ‘uesta J (see Quirce et al). 2003;111:788-94
‘jambotti JM (see Samee et al). 2003;111:1205-11 ‘uesta J (see Sastre et al). 2003;111:985-94
(Rapid publications) ‘ullinan P (see Jeal H et al). 2003;111:795-9
ianferoni A (see Novembre et al). 2003;111:1405-6 ‘unard R, Kelly CJ. Immune-mediated renal disease.
(Letters to the editor) 2003:111:S637-S644
‘isternas MG, Blanc PD, Yen IH, Katz PP, Earnest G, Eis- ‘undall M (see Wenzel et al). 2003;111:1345-52
ner MD, Shiboski S, Yelin EH. A comprehensive study ‘urbishley L (see Gore et al). 2003;111:784-7
of the direct and indirect costs of adult asthma. ‘urran-Everett D (see Ewbank et al). 2003;111:155-61
2003;111:1212-8 ‘urrie GP (see Lee et al). 2003;111:337-41
‘ockburn I (see Stafford et al). 2003;111:729-35 ‘ustovic A, Simpson BM, Simpson A, Hallam CL, Marolia
‘odlin S, Soh C, Lee T, Lavender P. Characterization of a H, Walsh D, Campbell J, Woodcock A. Current mite,
palindromic enhancer element in the promoters of IL4, cat, and dog allergen exposure, pet ownership, and sen-
IL5, and IL13 cytokine genes. 2003;111:826-32 sitization to inhalant allergens in adults. 2003;111:402-7
‘ohen S, Dworetzky M, Frick OL. Coca and Cooke on the ‘ustovic A (see Gore et al). 2003;111:784-7
classification of hypersensitiveness. 2003; 111:205-10
(The allergy archives) (Correction 2003;111:609) D
‘ohen SG, Frankland AW, Dworetzky M. Noon and Free- Dahlén B (see Gyllfors et al). 2003;111:1116-21
man on prophylactic inoculation against hay fever. Dahlén S-E (see Gyllfors et al). 2003;111:1116-21
2003:111:1142-50 (The allergy archives) D’ Amato G (see Liccardi et al). 2003;111:1410-2
‘ohn RD (see Arbes et al). 2003;111:408-14 (Letters to the editor)
‘olilla S, Nicolae D, Pluzhnikov A, Blumenthal MN, Danz N (see Kaul et al). 2003;111:1262-8
1430 Author index J ALLERGY CLIN IMMUNOL
JUNE 2003
Darsow U (see Kerschenlohr et al). 2003;111:195-7 3 and natural Pru p 3, a major peach allergen, show
(Letters to the Editor) equivalent immunologic reactivity: a new tool for the
Das J (see Herrick et al). 2003;111:1087-94 diagnosis of fruit allergy. 2003;111:628-33
Davies DE, Wicks J, Powell RM, Puddicombe SM, Hol Dinh QT (see Groneberg et al). 2003;111:1099-105
gate ST. Airway remodeling in asthma: new insights Dirksen A (see Linneberg et al). 2003;111:847-53
2003;111:215 25 Dodd CC (see Naisbitt et al). 2003;111:1393-40
Dawson M (see Ono et al). 2003;111:1 185-99 Dodge AM (see Panzer et al). 2003;111:308-12
de Bruin-Weller MS (see Oosting et al). 2003:111:203-4 Domae M, Sagara H, Sakaue M, Fukuda T, Kamikawa Y
(Letter reply) The antiallergic drug oxatomide promotes human
De Carolis C (see Perricone et al). 2003;111:1137 eosinophil apoptosis and suppresses IL-5—induced
(Correspondence) eosinophil survival. 2003;111:567-72
de Clerck LS (see Ebo et al). 2003;111:1414 Donfack J, Kogut P, Forsythe S, Solway J, Ober C.
(Correspondence ) Sequence variation in the promoter region of the cholin
de Guia TS (see Lai et al). 2003;111:263-8 ergic receptor muscarinic 3 gene and asthma and atopy
de Jesus AR (see Medeiros et al). 2003;111:947-51 2003;111:527-32
de Lange EE (see Samee et al). 2003:111:1205-11 Dorinsky PM (see Busse et al). 2003;111:57-65
Rapid publication Dorscheid DR, Low E, Conforti A, Shifrin S, Sperling Al,
le las Heras M (see Quirce et al). 2003:111:788-94 White SR. Corticosteroid-induced apoptosis in mouse
le Las Heras M (see Sastre et al). 2003;111:985-94 airway epithelium: effect in normal airways and aftet
de Marco R (see Verlatoe t al). 2003;111:1232-8 allergen-induced airway inflammation. 2003;1 1 1:360-6
erdier MG (see Elmstahl et al). 2003;111:91-6 Draper A (see Jeal H et al). 2003;111:795-9
Verdier MG (see Norjavaara and de Verdier) Dreborg S. Dietary prevention of allergy, atopy, and allet
1003: 111:736-42 gic diseases. 2003;1 1 1:467-70 (Editorial) (Correction
le Weck A (see Zemann et al). 2003:111:1069-75 2003;111:1202)
Weert MM (see Verster et al). 2003;1 11:623-7 Dreskin S (see Ewbank et al). 2003;111:155-61
Decard S (see Kerschenlohr et al). 2003;111:195-7 Dreskin SC (see Anand et al). 2003;111:1133-6
(Letters to the Editor), 869-74 (Letters to the editor)
Decosta P (see Wahn et al). 2003;111:763-9 Drupka D (see Gyllfors et al). 2003;111:1116-21
Deichmann K (see Sengler et al). 2003;111:515-9 Duarte AJdS (see Victor et al). 2003;111:269-77
Deichmann KA (see Kruse et al). 2003:1 11:11 799 Dudden R (see Bender et al). 2003:111:770-6
le] Giudice MM, ¢ ipasso M., MaielloN Capristo C Pia Dufour N (see Fellrath et al). 2003:111:854-61
centini GL, Brunese FP, Capristo AF. Exhaled nitric Dunson D (see Chulada et al). 2003-111
oxide and atopy in children. 2003;111:193 Durham SR (see Francis et al). 2003;1 11:1
(Letters to the editor) (Rapid publications)
DelateT, Motheral B. Conclusions of cost-effectiveness for Duro G (see Stumvoll et al). 2003;111:974
an asthma intervention might not be warranted Durrell B (see Gore et al). 2003:111:784-7
’003-111:654-5 (¢ orrespondence ) Duschl A (see Hahn et al). 2003:111:1361-9
Denburg J (see Menzies-Gow et al). 2003:111:714-9 Diizgiines N (see Konduri et al). 2003-1 11:321-7
Rapid publications Dworetzky M (see Cohen et al). 2003;111:205-10 (The
Deniz Y (see Corren et al). 2003:111:87-90 allergy archives), 1142-50 (The allergy archives)
(Brief communication Dykewicz MS. Rhinitis and sinusitis. 2003:111:S520-S52¢
Depta JPH (see Naisbitt et al). 2003:111:1393-403
Devendra D. Immunologic endocrine disorders E
2003:111:S624-S636 Earnest G (see Cisternas et al). 2003:111:12
Dharmasaroja P. Structural similarity between the bee Ebner C (see Himly et al). 2003:111:882-8
enom peptides and the immunodominant human Ebner H (see Himly et al). 2003;111:882-8
myelin basic proteins: role for pathogenesis of acute Ebo DG, Stevens WJ, Bridts C, de Clerck LS. Clinical iab
disseminated encephalomyelitis. 2003;111:426-8 oratory assessment of IgE. 2003:111:1414
(Letters to the editor) (Correspondence)
Diav-CitrinO , Shechtman S, Aharonovich A, Moerman | I chechipia Madoz S (see Tabar-Purroy et al)
Arnon J, Wajnberg R, Ornoy A. Pregnancy outcome 2003;111:415-9
after gestational exposure to loratadine or antihista Eddleston J. Christiansen S¢ . Jenkins GR, Koziol JA,
mines: a prospective controlled cohort study Zuraw BI Bradykinin increases the in vivo expression
2003;111:1239-43 of the CXC chemokine receptors CXCRI and CXCR2
Diaz Pena JM (see Garcia-Ara et al). 2003:111:647-8 in patients with allergic rhinitis. 2003;111:106-12
(Letters to the editor) Edwards LD (see Busse et al). 2003;111:57-65
Diaz-Perales A, Sanz ML, Garcia-CasadoG , Sanchez Eggleston PA (see Matsui et al). 2003;111:396-401
Monge R, Garcia-Selles FJ, Lombardero M, Polo F, Egmar A-C (see Almqvist et al). 2003;111:800-6
Gamboa PM, Barber D, Salcedo G. Recombinant Pru p Eichenfield LF, Beck L. Elidel (pimecrolimus) cream |‘ (
J ALLERGY CLIN IMMUNOL Author index 1431
VOLUME 111, NUMBER 6
a nonsteroidal topical agent for the treatment of atopic Ferreira IM (see Sandrini et al). 2003;111:313-20
dermatitis. 2003;111:1153-68 (New products) Feuchtinger T, Bartz H, von Berg A, Riedinger F,
Eidelman DH (see Eum et al). 2003;111:1049-61 Brauburger J, Stenglein S, Wahn U, Schauer U. Treat-
Eijken EJE (see Verster et al). 2003;111:623-7 ment with omalizumab normalizes the number of
Eisner MD (see Cisternas et al). 2003;111:1212-8 myeloid dendritic cells during the grass pollen season.
Ekstrém H (see Elmstahl et al). 2003;111:91-6 2003;111:428-30 (Letters to the editor)
Elias J (see Chakir et al). 2003;111:1293-8 Figueiredo JP (see Medeiros et al). 2003;111:947-51
Elias JA (see Toda et al). 2003;111:875-81 Filipiak-Pittroff B (see von Berg et al). 2003;111:533-40
Elias JA (see Zheng et al). 2003;111:720-8 Finkelstein SN (see Stafford et al). 2003;111:729-35
(Rapid publications) Finn A, Gross G, van Bavel J, Lee T, Windom H, Everhard
Elmstahl S, Ekstr6m H, Galvard H, Johnell O, de Verdier F, Fowler-Taylor A, Liu J, Gupta N. Omalizumab
MG, Norjavaara E. Is there an association between improves asthma-related quality of life in patients with
inhaled corticosteroids and bone density in post- severe allergic asthma. 2003;111:278-84
menopausal women? 2003;111:91-6 Finn A Jr (see Simons et al). 2003;111:617-22
Erb KJ (see Hahn et al). 2003:111:1361-9 Finn AF Jr (see Wahn et al). 2003;111:763-9
Erpenbeck VJ, Hohlifeld JM, Volkmann B, Hagenberg A, Fiocchi A, Bouygue GR, Restani P, Gaiaschi A, Terrac-
Geldmacher H, Braun A, Krug N. Segmental allergen ciano L, Martelli A. Anaphylaxis to rice by inhalation.
challenge in patients with atopic asthma leads to 2003;111:193-5 (Letters to the editor)
increased IL-9 expression in bronchoalveolar lavage Fischer A (see Groneberg et al). 2003;111:1099-105
fluid lymphocytes. 2003;111:1319-27 Fischer TC (see Groneberg et al). 2003;111:1099-105
Ertl R (see Wen et al). 2003;111:1307-18 Fiset P-O, Soussi-Gounni A, Christodoulopoulos P, Tulic
Erwin EA (see Platts-Mills et al). 2003;111:123-30 M, Sobol SE, Frenkiel S, Lavigne F, Lamkhioued B,
Espinosa K, Bossé Y, Stankova J, Rola-Pleszczynski M. Hamid Q. Modulation of allergic response in nasal
CysLT, receptor upregulation by TGF-B and IL-13 is mucosa by antisense oligodeoxynucleotides for IL-4
associated with bronchial smooth muscle cell prolifera- 2003;111:580-6
tion in response to LTD4. 2003;111:1032-40 Fitch K (see Anderson et al). 2003;111:45-50
Eum S-Y, Maghni K, Hamid Q, Eidelman DH, Campbell Fleisher TA (see Jirapongsananuruk et al). 2003;111:374-9
H, Isogai S$, Mariin JG. Inhibition of allergic airways Flood-Page P (see Menzies-Gow et al). 2003;111:714-9
inflammation and airway hyperresponsiveness in mice (Rapid publications)
by dexamethasone: role of eosinophils, [L-5, eotaxin, Foetisch K, Westphal S, Lauer I, Retzek M, Altmann F,
and IL-13. 2003;111:1049-61 Kolarich D, Scheurer S, Vieths S. Biological activity of
Everhard F (see Finn et ai). 2003;111:278-84 IgE specific for cross-reactive carbohydrate determi-
Ewbank PA, MurrayJ, SandersK, Curran-Everett D, Dre- nants. 2003;111:889-96
skin S, Nelson HS. A double-blind, placebo-controlled Folds JD, Schmitz JL. Clinical and laboratory assessment
immunotherapy dose-response study with standardized of immunity. 2003;111:S702-S711
cat extract. 2003;111:155-61 Fontana L (see Perricone et al). 2003;111:1137
(Correspondence)
F Ford JL (see Caplan et al). 2003;111:1274-7
Fang Q (see Wen et al). 2003;111:1307-18 Forster J (see Sengler et al). 2003;111:515-9
Farioli L (see Pastorello et al). 2003;111:350-9 Forsythe S (see Donfack et al). 2003;111:527-32
Farrell J (see Naisbitt et al). 2003:111:1393-403 Fortunato D (see Pastorello et al). 2003;111:350-9
Fathman CG (see Shearer and Fathman). 2003;111:S766-S773 Foster PS (see Kruse et al). 2003;111:117-22
Fattouh R (see Cates et al). 2003:111:1076-86 Foster PS (see Zimmermann et al). 2003;111:227-42
Faulkner S (see Ziska et al). 2003:111:290-5 Fowler-Taylor A (see Finn et al). 2003;111:278-84
Feldman HI (see Apter et al). 2003;111:1219-26 Francis JN, Till SJ, Durham SR. Induction of IL-
Feldman HI (see George et al). 2003;111:967-73 10*CD4+CD25+* T cells by grass pollen immunothera-
Fellrath J-M, Kettner A, Dufour N, Frigerio C, Schnee- py. 2003;111:1255-61 (Rapid publications)
berger D, Leimgruber A, Corradin G, Spertini F. Aller- Frankland AW (see Cohen et al). 2003;111:1142-50
gen-specific T-cell tolerance induction with allergen- (The allergy archives)
derived long synthetic peptides: results of a phase I Franks RW (see Brown et al). 2003;111:187-92
trial. 2003;111:854-61 Freedman TG (see George et al). 2003;111:967-7
Ferguson BJ. Antifungal nasal washes for chronic rhinosi- Frenkiel S (see Fiset et al). 2003;111:580-6
nusitis: what's therapeutic-the wash or the antifungal? Frenz DA (see Ziska et al). 2003;111:290-5
2003;i11:1137-8 (Correspondence) Frew AJ. Advances in environmental and occupational dis-
Fernandez-Nieto M (see Quirce et al). 2003:111:788-94 orders. 2003;111:S824-S829
Fernandez-Nieto M (see Sastre et al). 2003-1 11:985-94 Frew AJ. Immunotherapy of allergic disease.
Ferreira F (see Himly et al). 2003;111:882-8 2003;111:S712-S719
Ferreira F (see Schmid-Grendelmeier et al) Frick OL (see Cohen et al). 2003;111:205-10
2003; 111:1328-36 (The allergy archives)
1432 Author index J ALLERGY CLIN IMMUNOL
JUNE 2003
Friedman W (see Arbes et al). 2003;111:408-14 Ghezzo H (see Nguyen et al). 2003;111:807-12
Frierson H (see Steinke et al). 2003;111:342-9 Gibney CA (see Naisbitt et al). 2003;111:1393-403
Frigerio C (see Fellrath et al). 2003;111:854-61 Gibson PG (see Wark et al). 2003;111:952-7
Frolund L (see Linneberg et al). 2003;111:847-53 Gilmore T (see Casale et al). 2003;111:S835-S842
Fujita A (see Higa et al). 2003;111:1299-306 Giuffrida MG (see Pastorello et al). 2003;111:350-9
Fujita H (see Kakinuma et al). 2003;1 1 1:592-7 Gold D (see Platts-Mills et al). 2003;111:123-30
Fujitsu Y (see Fukuda et al). 2003:111:520-6 Gold P (see Gagnon et al). 2003;111:1404-5
Fukakusa M (see Chakir et al). 2003;111:1293-8 (Letters to the editor)
Fukuda K, Fujitsu Y, Seki K, Kumagai N, Nishida T. Dif- Goncharova §S (see Cates et al). 2003;111:1076-86
ferential expression of thymus- and activation-regulated Goodenow MM (see Sleasman and Goodenow)
chemokine (CCL17) and macrophage-derived 2003; 11 1:S582-S592
chemokine (CCL22) by human. 2003;111:520-6 Gore RB. Durrell B, Bishop S, Curbishley L, Woodcock A,
ukuda T (see Domae et al). 2003:111:567-72 Custovic A. High-efficiency particulate arrest—filter vac-
ukuda T (see Toda et al). 2003:111:875-81 uum cleaners increase personal cat allergen exposure in
Fusaro AE (see Victor et al). 2003;111:269-77 homes with cats. 2003;111:784-7
Gorska M (see Alam and Gorska). 2003;111:S476-S485
G Green BJ, Mitakakis TZ, Tovey ER. Allergen detection
Gagnon R, Julien M, Gold P. Selective celecoxib-associat- from || fungal species before and after germination
ed anaphylactoid reaction. 2003;111:1404-5 2003; 111:285-9
(Letters to the editor) Griffin GE (see Cooper et al). 2003;1 1 1:995-1000
aiaschi A (see Fiocchi et al). 2003;111:193-5 Griot-Wenk M (see Zemann et al). 2003;111:1069-75
(Letters to the editor) Groneberg DA, Weiker P, Fischer TC, Dinh QT, Griitzkau
jajewska BU (see Cates et al). 2003:111:1076-86 A, Peiser C, Wahn U, Henz BM, Fischer A. Downregu
alvard H (see Elmstahl et al). 2003:111:91-6 lation of vasoactive intestinal polypeptide receptor
amboa PM (see Diaz-Perales et al). 2003;111:628-33 expression in atopic dermatitis. 2003;111:1099-105
angadharam PRJ (see Konduri et al). 2003;111:321-7 Gross G (see Finn et al). 2003;111:278-84
arabrant D, Schweitzer S. Epidemiology of latex sensiti Grote M, Valenta R, Reichelt R. Abortive po!len germina-
zation. 2003;111:652-3 (Letter reply) tion: a mechanism of allergen release in birch, alder
arcia-Ara MC, Valls Sanchez A, Boyano Martinez MT, and hazel revealed by immunogold electron
Diaz Pena JM. Cow’s milk—dependent, exercise microscopy. 2003;111:1017-23
induced anaphylaxis: case report of a patient with previ- Griibl A (see von Berg et al). 2003;111:533-40
ous allergy to cow’s milk. 2003;111:647-8 Grubmayr K (see Himly et al). 2003:111:882-8
(Letters to the editor) Gruchalla RS. Drug allergy. 2003;1 1 1:S548-S559
arcia-Casado G (see Diaz-Perales et al). 2003;111:628-33 Grunewald SM (see Hahn et al). 2003;111:1361-9
arcia-Figueroa BE (see Tabar-Purroy et al) Griitzkau A (see Groneberg et al). 2003;111:1099-105
2003;111:415-9 Guerin L (see Leduc et al). 2003;111:897-9
arcia-Selles FJ (see Diaz-Perales et al). 2003:111:628-33 (Letters to the editor)
arofto LP (see Pastorello et al). 2003:111:350-9 Gupta N (see Finn et al). 2003;111:278-84
autrin D (see Nguyen et al). 2003:111:807-12 Gutgesell C. Atopic dermatitis and the clinical effect of
savin LA (see Ho et al). 2003:111:498-502 house dust mite avoidance. 2003;111:202-3
sebhard DE (see Ziska et al). 2003;111:290-5 (Correspondence)
sebhardt T (see Lorentz et al). 2003;111:1062-8 Gutierrez-Ramos J-C (see Cates et al). 2003:111:1076-86
seha RS (see Binstadt et al). 2003-;1 1 1:697-703 (Rostrum) Gwaltney JM (see Zambrano et al). 2003;111:1008-16
ieha RS (see Bonilla and Geha). 2003:111:S571-S581 Gyllfors P, Bochenek G, Overholt J, Drupka D, Kumlin M,
ieldmacher H (see Erpenbeck et al). 2003;111:1319-27 Sheller J, Nizankowska E, Isakson PC, Mejza F,
selfand E (see Casale et al). 2003:111:S835-S842 Lefkowith JB, Dahlén S-E, Szezeklik A, Murray JJ,
ieorge M, Freedman TG, Norfleet AL, Feldman HI, Apter Dahlén B. Biochemical and clinical evidence that
AJ. Qualitative research-enhanced understanding of aspirin-intolerant asthmatic subjects tolerate the
patients’ beliefs: results of focus groups with low cyclooxygenase 2-selective analgetic drug celecoxib
income, urban, African American adults with asthma 2003-11 1:1116-21
2003:111°:967-73
George M (see Apter et al) 2003;111:1219-26 H
Geraci D (see Stumvoll et al). 2003:111:974-9 Hagenberg A (see Erpenbeck et al). 2003;111:1319-27
Gern JE (see Kessel JM et al). 2003:111:1024-31 Hahn C. Teufel M, Herz U, Renz H, Erb KJ, Wohlleben G,
Gern JE (see Simons et al). 2003;111:899-901 Brécker EB, Duschl A, Sebald W, Grunewald SM. Inhi-
(Letters to the editor) bition of the IL-4/IL-13 receptor system prevents aller-
Gevaert P( see Bachert et al). 2003:111:1131-2 gic sensitization without affecting established allergy in
(Letters to the editor) a mouse model for allergic asthma. 2003;111:136i-9
Gewirtz AM (see Henningson et al). 2003;111:S745-S753 Haider A (see Sengler et al). 2003;111:515-9
J ALLERGY CLIN IMMUNOL Author index 1433
VOLUME 111, NUMBER 6
Halken S, Hgst A, Niklassen U, Hansen LG, Nielsen F, tomly K. Differential roles for CD4 and CD8 T cells
Poulsen S, Osterballe O, Veggerby C, Poulsen LK. after diisocyanate sensitization: genetic control of T},2-
Effect of mattress and pillow encasings on children with induced lung inflammation. 2003;111:1087-94
asthma and house dust mite allergy. 2003;111:169-76 Hershey GK (see Zimmermann et al). 2003;111:227-42
Haliam CL (see Custovic et al). 2003;111:402-7 Hershey GKK. IL-13 receptors and signaling pathways: an
Hallsworth MP, Major PJ, Barnes J, Lee TH. What are the evolving web. 2003;111:677-90
priorities in basic asthma research? A United Kingdom Herva A (see Timonen et al). 2003;111:1249-54
perspective. 2003:111:251-5 (Rostrum) Herz U (see Hahn et al). 2003;111:1361-9
Halonen M (see Taussig et al). 2003;111:661-75 Hewitt J (see Wamboldt et al). 2003;111:509-14
Hamelmann E, Schleimer RP. Corticosteroid treatment in Heymann PW (see Zambrano et al). 2003;111: 1008-16
bronchial asthma: for better or for worse? Higa S, Hirano T, Kotani M, Matsumoto M, Fujita A, Sue-
2003; 111:248-50 (Editorial) mura M, Kawase I, Tanaka T. Fisetin, a flavonol,
Hamid Q. Airway remodeling in asthma. 2003;111:1420-1 inhibits T,,2-type cytokine production by activated
(Images in allergy and immunology) human basophils. 2003; 11 1:1299-306
Hamid Q. Gross pathology and histopathology of asthma. Himly M, Jahn-Schmid B, Pittertschatscher K, Bohle B,
2003;111:431-2 (Images in allergy and immunology) Grubmayr K, Ferreira F, Ebner H, Ebner C. IgE-mediat-
Hamid Q. Inflammatory cells, cytokine and chemokine ed immediate-type hypersensitivity to the pyrazolone
expression in asthma immunocytochemistry and in situ drug propyphenazone. 2003;111:882-8
hybridization. 2003;111:902-3 Himly M (see Schmid-Grendelmeier et al).
(Images in allergy and immunology) 2003;111:1328-36
Hamid Q, Tulic’ MK, Liu MC, Mogbe! R. Inflammatory Hindmarch I (see Casale et al). 2003;111:S835-S842
cells in asthma: mechanisms and implications for thera- Hirahara K (see Sato et al). 2003;111:143-8
py. 2003;111:S5-S17 Hirano T (see Higa et al). 2003;111:1299-306
Hamid Q (see Bochner and Hamid). 2003;111:S819-S823 Ho J, Bender BG, Gavin LA, O’Connor SL, Wamboldt MZ,
Hamid Q (see Chakir et al). 2003;111:1293-8 Wamboldt FS. Relations among asthma knowledge,
Hamid Q (see Eum et al). 2003;111:1049-61 treatment adherence, and outcome. 2003;111:498-502
Hamid Q (see Fiset et al). 2003-:111:580-6 Hoff M, Triieb RM, Ballmer-Weber B-K, Vieths S,
Hamid Q (see Menzies-Gow et al). 2003;111:714-9 Wuethrich B. Immediate-type hypersensitivity reaction
(Rapid publications) to ingestion of mycoprotein (Quorn) in a patient aller-
Hamid Q (see Nag et al). 2003;111:558-66 gic to molds caused by acidic ribosomal protein P2.
Hamid QA (see Toda et al). 2003;111:875-81 2003;111:1106-10
Hamilton R (see Bernstein et al). 2003;111:610-6 Hoffmann A (see Kaul et al). 2003;111:1262-8
Hamilton RG, Adkinson NF Jr. Clinical and laboratory Hohlfeld JM (see Erpenbeck et al). 2003;111:1319-27
assessment of IgE-dependent hypersensitivity. Holberg CJ (see Taussig et al). 2003;111:661-75
2003:111:S687-S701 Holgate ST, Peters-Golden M. Introduction: The anti-
Hamilton RG. Clinical laboratory assessment of IgE. inflammatory role of cysteinyl leukotriene receptor
2003;111:1414-6 (Letter reply) antagonists in asthma. 2003;111:S1-S4
Hansen LG (see Halken et al). 2003;111:169-76 Holgate ST, Peters-Golden M, Panettieri RA, Henderson
Hanson IC (see Moylett and Hanson). 2003;111:S754-S765 WR Jr. Roles of cysteinyl leukotrienes in airway
Harris AG (see Horak et al). 2003;111:653-4 (Letter reply) inflammation, smooth muscle function, and remodeling.
Harris J (see Jeal H et al). 2003;111:795-9 2003;111:S18-S36
Harvey PD (see Casale et al). 2003;111:S835-S842 Holgate ST (see Davies et al). 2003;111:215-25
Harvima R (see Palosuo et al). 2003;111:1386-92 Holtappels G (see Bachert et al). 2003;111:1131-2
Hatley TK (see Zambrano et al). 2003;111: 1008-16 (Letters to the editor)
Haver K (see Stafford et al). 2003;111:729-35 Holtzman MJ. Where are the gaps in asthma research? A
Hayden FG (see Zambrano et al). 2003;111:1008-16 counter-perspective. 2003;111:244-7 (Editorial)
Heddle RJ (see Brown et al). 2003;111:187-92 Holzmann D (see Schmid-Grendelmeier et al).
Hedlin G (see Almqvist et al). 2003;111:800-6 2003;111:1328-36
Hedlin G (see Wahn et al). 2003;111:763-9 Homer RJ (see Zheng et al). 2003;111:720-8
Heinzmann A (see Sengler et al). 2003:111:515-9 (Rapid publications)
Helm RM (see Kelso et al). 2003;111:650-1 Hopkins JE (see Naisbitt et al). 2003;111:1393-403
(Letters to the editor) Hopper N (see Leung and Hopper). 2003;111:34-5
Helm RM (see Pomés et al). 2003;111:640-5 (Editorial)
Henderson WR Jr (see Holgate et al). 2003;111:S18-S36 Horak F, Stiibner UP Harris AG. Decongestant effects of
Henningson CT Jr, Stanislaus MA, Gewirtz AM. Embryon- antihistamines: a class effect? 2003;111:653-4
ic and adult stem cell therapy. 2003;111:S745-S753 (Letter reply)
Hensley MJ (see Wark et al). 2003;111:952-7 Hgst A (see Halken et al). 2003;111:169-76
Henz BM (see Groneberg et al). 2003;111:1099-105 Howarth P (see Bachert et al). 2003;111:1131-2
Herrick CA, Das J, Xu L, Wisnewski AV, Redlich CA, Bot- (Letters to the editor)
1434 Author index J ALLERGY CLIN IMMUNOL
JUNE 2003
Huang C-K (see Morafo et al). 2003;111:1122-8 K
Huang J-L (see Yao et al). 2003;111:1285-92 Kabesch M, Peters W, Carr D, Leupold W, Weiland SK,
Hubbard R (see Sheikh et al). 2003;111:131-5 von Mutius E. Association between polymorphisms in
Hurley C (see Roberts et al). 2003;111:491-7 Caspase recruitment domain containing protein 15 and
Hwang ST (see Blauvelt et al). 2003;1 1 1:S560-S570 allergy in two German populations. 2003; 11 1:813-7
Kagey-Sobotka A (see Matsui et al). 2003;111:396-401
| Kahl LE (see Brasington et al). 2003;111:S593-S601
leki K (see Matsukura et al). 2003;111:1337-44 Kakinuma T, Saeki H, Tsunemi Y, Fujita H, Asano N, Mit-
Ikenaga T (see Watanabe et al). 2003;111:587-91 sui H, Tada Y, Wakugawa M, Watanabe T, Torii H,
Inaba K (see Kusunoki et al). 2003:111:136-42 Komine M, Asahina A, Nakamura K, Tamaki K
Isakson PC (see Gylifors et al). 2003;111:1116-21 Increased serum cutaneous T cell—attracting chemokine
Isogai S (see Eum et al). 2003:111:1049-61 (CCL27) levels in patients with atopic dermatitis and
Israel E. Study design is a major determinant of whether psoriasis vulgaris. 2003;111:592-7
equivalence or superiority 1s demonstrated Kalkkinen N (see Palosuo et al). 2003;111:1386-92
2003;111:1413-4 (Letter reply) Kamikawa Y (see Domae et al). 2003;111:567-72
Issazadeh-Navikas S (see Matheu et al). 2003;111:550-7 Kamin W (see Sengler et al). 2003;111:515-9
lyoda T (see Kusunoki et al). 2003;111:136-42 Kanny G (see Leduc et al). 2003;111:897-9
(Letters to the editor)
J Karasuyama H (see Sato et al). 2003;111:143-8
Jackson CM (see I ipworth et al). 2003:111:653 Karnani R (see Bernstein et al). 2003;111:610-6
(Correspondence Katakai T (see Kusunoki et al). 2003;111:136-42
Jahn-Schmid B (see Himly et al). 2003:111:882-8 Katsukura H (see Watanabe et al). 2003;111:1375-85
James SP. Immunologic, gastroenterologic, and hepatobil Katz PP (see Cisternas et al). 2003:111:1212-8
iary disorders. 2003:111:S645-S658 Kauffmann F (see Maccario J et al). 2003;111:750-6
Jardim JR (see Sandrini et al). 2003;111:313-20 Kaul S, Scheurer S, Danz N, Schicktanz S, Vieths S, Hoff-
Jarjour NN (see Kelly et al). 2003:111:79-86 mann A. Monoclonal IgE antibodies against birch
Jarjour NN (see Liu L-Y et al). 2003:1 pollen allergens: novel tools for biological characteriza
Jarjour NN (see Panzer et al). 2003:111 tion and standardization of allergens. 2003;111:1262-8
Jazrawi E (see Roche et al). 2003-111 Kawaguchi M (see Matsukura et al). 2003;111:1337-44
Jeal H, Draper A, Jones M, Harris J, Welsh K, Taylor AN, Kawase I (see Higa et al). 2003;111:1299-306
Cullinan P. HLA associations with occupational sensiti Kay AB (see Larché et al). 2003:111:450-63
zation to rat lipocalin allergens: a model for other ani Kay B (see Menzies-Gow et al). 2003;111:714-9
mal allergies? 2003;111:795-9 (Rapid publications)
Jenkins GR (see Eddleston et al). 2003:111:106-12 Kayaba H (see Adachi et al). 2003;111:113-6
Jeppesen DL (see Rosenfeldt et al). 2003:111:389-95 Kelly CJ (see Cunard and Kelly). 2003;111:S637-S644
Jerkic S-P (see Sengler et al). 2003:111:515-9 Kelly EA (see Liu L-Y et al). 2003;111:818-25
Jin SM (see Lee et al). 2003:111:1278-84 Kelly EAB, Busse WW, Jarjour NN. A comparison of the
Jirapongsananuruk O, Malech HL, Kuhns DB, Niemela JE, airway response to segmental antigen bronchoprovocation
Brown MR, Anderson-Cohen M, Fleisher TA. Diagnos in atopic asthma and allergic rhinitis. 2003;111:79-86
tic paradigm for evaluation of male patients with chron Kelly EAB (see Panzer et al). 2003;111:308-12
ic granulomatous disease, based on the dihydrorho Kelsay K (see Wamboldt et al). 2003;111:509-14
damine 123 assay. 2003:111:374-9 Kelso JM, Bardina L, Beyer K. Allergy to canned tuna
Johansson SGO (see Bachert et al). 2003:111:1131-2 2003;111:901 (Letters to the editor)
(Letters to the editor) Kelso JM, Connaughton C, Helm RM, Burks W. Psychoso
Johnell O (see Elmstahl et al). 2003;111:91-6 matic peanut allergy. 2003;111:650-1
Jokelainen J (see Timonen et al). 2003:111:1249-54 (Letters to the editor)
Jones M (see Jeal H et al). 2003:111:795-9 Kern EB (see Ponikau et al). 2003;111:1138-40
Jordana M (see Cates et al). 2003;111:1076-86 (Letter reply )
Jorgensen T (see Linneberg et al). 2003:111:847-53 Kerschenlohr K, Decard S, Darsow U, Ollert M, Wollen
980-4 berg A. Clinical and immunologic reactivity to aeroal
Jovanovski E (see Moretti et al). 2003;111:479-83 lergens in “intrinsic” atopic dermatitis patients
Julien M (see Gagnon et al). 2003:111:1404-5 2003;111:195-7 (Letters to the editor)
(Letters to the editor) Kerschenlohr K, Decard S, Przybilla B,W ollenberg A
Juniper EF, Rohrbaugh T, Meltzer EO. A questionnaire to Atopy patch test reactions show a rapid influx of
measure quality of life in adults with nocturnal allergic inflammatory dendritic epidermal cells in patients with
rhinoconjunctivitis. 2003:111:484-90 extrinsic atopic dermatitis and patients with intrinsic
Just J. Clinical significance of bronchoalveolar cell pro- atopic dermatitis. 2003;111:869-74
files in childhood asthma. 2003;111:204 Kessel JM, Gern JE, Vrtis RF, Sedgwick JB, Busse WW
(Letter reply) Ligation of intercellular adhesion molecule 23 inhibits